Latest News-Samsung Biologics Co. Ltd. Mediaroom_Page

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

INCHEON, South Korea, Oct. 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into ...

2020-10-20 19:00 9339

Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing

INCHEON, South Korea, Oct. 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into ...

2020-10-19 19:00 10239

Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases

INCHEON, South Korea, Sept. 23, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Kanaph Thera...

2020-09-24 08:00 1515

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca ...

2020-09-22 07:00 12805

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

Samsung Biologics signs development agreement with Panolos for solid tumor treatment

INCHEON, South Korea, Sept. 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into...

2020-09-17 08:43 2624

Samsung Biologics launches S-CHOice cell line expression technology

INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today held an...

2020-08-05 09:09 2926

Samsung Biologics launches S-CHOice cell line expression technology

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced to...

2020-07-21 20:20 16778

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

SONGDO, South Korea, July 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced a plan t...

2020-07-21 10:13 15999

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

SONGDO, South Korea, July 15, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Th...

2020-07-15 13:46 1838

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expand...

2020-07-12 08:00 1788

Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020

SONGDO, South Korea, June 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the launc...

2020-06-08 19:00 1826

Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) an...

2020-05-22 07:11 6464

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has at...

2020-05-20 07:11 1864

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)

SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia T...

2020-04-23 08:00 1471

Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support

SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced Q1...

2020-04-22 19:00 6142

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) ...

2020-04-10 11:39 2673

Samsung Biologics named Champion in 2020 CMO Leadership Awards

SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it ...

2020-04-08 20:00 1283

Samsung Biologics named Champion in 2020 CMO Leadership Awards

Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment

SONGDO, South Korea, April 5, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a str...

2020-04-06 08:00 1131

Samsung Biologics expands leadership for CDO business

SONGDO, South Korea, March 30, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has appointedEun ...

2020-03-30 21:00 1502

Samsung Biologics expands leadership for CDO business

Samsung Biologics Adds Greater Expertise and Diversity to Its Board

SONGDO, South Korea, March 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the app...

2020-03-20 20:00 2454